True to form, James Watson didn't mince words at a recent lecture at the Salk Institute for Biological Studies, where he said that the majority of cancer research is "irrelevant" and got into a verbal tussle with fellow Nobelist Roger Tsien.

The San Diego Union-Tribune reports that Watson, in a talk about the role of oxidants in cancer and diabetes, questioned the utility of sequencing cancer genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Defending Open Access

Money and the Prize

Gathering the Data

A Year On

The Missing Drugs

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.